Takeda Pharmaceutical (TKPHF) Free Cash Flow (2018 - 2026)

Takeda Pharmaceutical's Free Cash Flow history runs 9 years deep, the most recent figure standing at $770.9 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 56.6% year-over-year to $770.9 million; the TTM figure through Mar 2026 stood at $8.1 billion (down 1.81% YoY), while the FY2026 annual figure was $8.1 billion, down 2.07% from the prior year.
• Free Cash Flow was $770.9 million for Q1 2026 at Takeda Pharmaceutical, down from $2.7 billion in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $2.9 billion in Q4 2022 to a low of $770.9 million in Q1 2026.
• Historically, Free Cash Flow has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2023.
• The sharpest annual moves came in 2024 and 2026: Free Cash Flow soared 115.45% in 2024, then slumped 56.6% in 2026.
• A 5-year view of Free Cash Flow shows it stood at $2.9 billion in 2022, then sank by 55.07% to $1.3 billion in 2023, then soared by 115.45% to $2.8 billion in 2024, then dropped by 4.43% to $2.7 billion in 2025, then tumbled by 71.41% to $770.9 million in 2026.
• The last three Free Cash Flow figures came in at $770.9 million (Q1 2026), $2.7 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.